Researchers have adapted CAR-T therapy, used in cancer treatment, to combat HIV, achieving promising results in two patients. They received a single dose of genetically modified T cells, which suppressed the virus for nearly one year and two years, respectively, without the need for regular medications. Dr. Steven Deeks, the study leader from the University of California, emphasized the need for a safe and effective solution for HIV. Although CAR-T therapy has shown promising results, larger studies are needed to confirm its long-term efficacy. Nearly 40 million people live with HIV worldwide, and current treatments are costly and require constant adherence. The new approach involves creating CAR-T cells capable of identifying and destroying HIV-infected cells, offering new hope in the search for a possible cure. Although the results are encouraging, experts warn that further research is needed to validate these findings.
Sources
Small study hints that revving up immune cells might help fight HIV
Un studiu recent arată că o singură sesiune de terapie celulară poate ține sub control infecția cu HIV
Studiu: O singură sesiune de terapie celulară poate ţine sub control infecţia cu HIV. Cum acționează
Latest News
20:22
A car dealer became the prince of Belgium, after the brother of the King officially recognized his paternity.
20:02
Oana Zoiu informed NATO allies about the incident with the destroyed maritime drone near Neptun Deep
19:57
Mark Zuckerberg bought a 19th-century Gothic castle in the southeast of Ireland, with an estimated value between 20 and 30 million euros.
19:52
Ciprian Ciucu announced that the request for STB to enter insolvency has been rejected: "So it is, I'm not a lawyer. Csf, ncsf..."
19:51
Ronaldinho returns to football at 46 years old, signing with the third division team in Italy, Ravenna FC
See more news